Intradermal Injection Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032

Report code : IS1344, Status : Published, Published on: Dec, 2022, Pages : 141 Pages, Format : PDF/PPT/Excel

Buying Options

Global Analysis: : $999

Global and Regional Analysis : $2799

Global Deep Dive Analysis : $5499

Competition Analysis : $399

Buy Now

Enquiry before buying

Description

The global Intradermal Injection market size was estimated to be US$ 3.3 billion in 2021 and is expected grow at a CAGR of 10.5% between 2023 to 2032.

Intradermal injection is the process by which a drug is injected into the skin. Injection methods may vary from subcutaneous (just beneath the skin's outer surface) to intradermal. Skincare, hormones, vaccines, and medications can all be delivered with an intradermal injection. It has gained popularity among patients because of the efficacy and absorption it delivers, for which a lesser amount is required over time.

Market Overview:

The global intradermal injection market has seen significant growth in recent years, especially among emerging markets owing to its easy administration, clinical superiority, and efficacy delivery mechanism (IGST), such as diabetes scales. The metered dose inhaler (MDI), previously used by pharmaceutical firms, is now a less-used treatment form because other mechanisms, such as tablets or syrups, have mainly displaced MDI products. Moreover, new product development, growing awareness about cosmetic surgery, and rising use of injectables will boost the growth. The growing trend of integrative therapies also propels the demand for these products shortly.

Reimbursement policies for these procedures will boost demand and sales in many developed countries due to rising prices leading to stricter emission policies and infections from prescription drugs that can be free of charge before December 2020.

The impacts of competition are witnessed across the Global Intradermal Injection market, where big players compete with price cuts, advertisements, and special offers to make their brands irresistible to consumers. Globally, Augment Therapeutics manufactures high-quality drugs, which pose a significant threat to Intradermal companies in North America and Europe.

Growth driving factors:

Increased Aesthetic Surgical Procedures and an Increasing Prevalence of Chronic Diseases to Promote Intradermal Injection Uptake. The market for intradermal injections is anticipated to rise faster due to TB's increased prevalence. According to WHO statistics, tuberculosis is the 13th most significant cause of death, and there are an estimated 10 million new cases each year. This has caused a dramatic increase in the TB diagnosis rate during the past ten years. This is one of the critical elements contributing significantly to expanding the intradermal injection market for tuberculin syringes.

Additionally, in North America and Europe, cosmetic operations are rising quickly. The intradermal vaccination lowers the possible antigen dosage, enhances the immune response, and lessens vaccination-related anxiety. Additionally, the demand for intradermal injections is rising as aesthetic procedures dominate local aesthetic procedures.

A healthcare setting's resources or refrigerator space are further constrained by the need for cold chain delivery and storage for almost all vaccinations. Each year, animal bites transmit rabies to around 17.4 million humans worldwide. Rabies is a viral illness that affects more than 150 regions and nations, and when it is spread to people, it can result in encephalitis. The price of cell-derived vaccinations for pre-exposure to rabies is significantly reduced via intradermal injections—the cost-savings associated with intradermal injections for rabies present significant market prospects.

Market segments:

Companies in the intradermal injection industry use both organic and inorganic methods. Product releases and product approvals are the major components of organic initiatives. Acquisitions, partnerships, and collaborations are other inorganic growth techniques used in the intradermal injection business. These expansion plans give market participants more geographic reach and commercial opportunities, which helps drive the intradermal injection market's overall expansion.

The intradermal injection market is further divided based on technology into long, short, and no needles. The devices with short needles are further divided into an intradermal liquid jet and ballistic intradermal injectors. In contrast, those without needles are divided into intradermal microinjection, microneedle arrays, and tattoo devices. While the short needle segment is anticipated to experience the highest CAGR between 2023 and 2032, regular-sized needles held most of the market share in 2021.

The market is divided into tuberculin skin testing, allergy testing, regional aesthetics, and other applications based on use. The category for tuberculin skin tests is anticipated to account for the most significant market share in 2021, while the segment for local aesthetics is anticipated to see the highest CAGR throughout the forecast period.

Companies in the intradermal injection industry strongly emphasize implementing a strategy of product development to satisfy customers' changing needs throughout the world, which also enables them to keep their brand identity in the global market.

Intradermal injection-related treatments and equipment have experienced constant innovation over the past several years, and various unique technologies are now included in this category to improve this industry. The adoption of intradermal injections has eventually grown due to the exponential rise in immunization and diagnostic rates for several issues during the past ten years.

Regional Analysis

Due to the presence of local competitors in the market and the better and simpler availability of intradermal injections in the area, North America is predicted to have the quickest growth in the market during the projection. In North America and Europe, improvements in the healthcare system and government support for intradermal injections are anticipated to expand the market for these procedures significantly. The US commercialization of several intradermal injections.

The FDA has been a significant driver of the global demand for intradermal injections. The intradermal injections market in Asia-Pacific is anticipated to expand significantly throughout the forecast period due to improvements in healthcare spending, rising market participant investment, and rising consumer awareness of the benefits of intradermal injections.

Growth restraining factors:

Unfavorable government policies that impede market expansion. Despite the benefits shown by several clinical studies, several obstacles prevent the use of intradermal injections. The major economies of Europe, the United States, and other industrialized nations depend on single-dose vaccines and have access to public or private insurance. Multi-dose forms are expected to be more prevalent in emerging nations, constrained by supply costs and availability.

Key Players

The Bristol-Myers Squibb Company, BD, OraSure Technologies Inc., West Pharmaceutical Services Inc., Kyoto Kagaku Co. LTD., Terumo Corporation, and others are some of the major market players active in the global intradermal injections market.

Segmentation of Intradermal Injection Market:

By Method:

By Application:

Tuberculin Skin Test
Allergy Test
Local Aesthetics
Others

By End Use:

Hospitals
Diagnostic Laboratories
Academics and Research Institutes
Others

By Geography

North America
- United States
- Canada
- Rest of North America
Europe
- Germany
- the United Kingdom
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
South America
- Brazil
- Rest of South America

Table Of Content

Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
Market Synopsis: Global Intradermal Injection Market
Global Intradermal Injection Market Qualitative Analysis
- Trends
  - Market trends
  - Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
  - Driving Forces
  - Hindering Forces
  - Opportunities
- COVID-19 impact
- Porter’s Five Forces Analysis
- Value Chain Analysis
Global Intradermal Injection Market Analysis and Forecast, by Method
- Overview and definitions
- Key segment analysis
- Global Intradermal Injection Market Estimates (US$ Mn), by Method, 2019 – 2032
  - Normal Sized Needles
  - Short Needle
  - Intradermal Microinjection
  - Microneedle Arrays
  - Tattoo Devices
  - Without Needle
  - Intradermal Liquid Jet Devices and
  - Ballistic Intradermal Injectors

Global Intradermal Injection Market Analysis and Forecast, by Application
- Overview and definitions
- Key segment analysis
- Global Intradermal Injection Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Tuberculin Skin Test
  - Allergy Test
  - Local Aesthetics
  - Others

Global Intradermal Injection Market Analysis and Forecast, by End Use
- Overview and definitions
- Key segment analysis
- Global Intradermal Injection Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Hospitals
  - Diagnostic Laboratories
  - Academics and Research Institutes
  - Others

Global Intradermal Injection Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Intradermal Injection Market Estimates (US$ Mn), by Region, 2019 – 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Intradermal Injection Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Intradermal Injection Market Estimates (US$ Mn), by Method, 2019 – 2032
  - Normal Sized Needles
  - Short Needle
  - Intradermal Microinjection
  - Microneedle Arrays
  - Tattoo Devices
  - Without Needle
  - Intradermal Liquid Jet Devices and
  - Ballistic Intradermal Injectors
- North America Intradermal Injection Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Tuberculin Skin Test
  - Allergy Test
  - Local Aesthetics
  - Others
- North America Intradermal Injection Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Hospitals
  - Diagnostic Laboratories
  - Academics and Research Institutes
  - Others
- North America Intradermal Injection Market Estimates (US$ Mn), by Country, 2019 – 2032
  - United States
  - Canada
  - Rest of North America

Europe Intradermal Injection Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Intradermal Injection Market Estimates (US$ Mn), by Method, 2019 – 2032
  - Normal Sized Needles
  - Short Needle
  - Intradermal Microinjection
  - Microneedle Arrays
  - Tattoo Devices
  - Without Needle
  - Intradermal Liquid Jet Devices and
  - Ballistic Intradermal Injectors
- Europe Intradermal Injection Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Tuberculin Skin Test
  - Allergy Test
  - Local Aesthetics
  - Others
- Europe Intradermal Injection Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Hospitals
  - Diagnostic Laboratories
  - Academics and Research Institutes
  - Others
- Europe Intradermal Injection Market Estimates (US$ Mn), by Country, 2019 – 2032
  - Germany
  - United Kingdom
  - Italy
  - France
  - Spain
  - Rest of Europe

Asia Pacific Intradermal Injection Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Intradermal Injection Market Estimates (US$ Mn), by Method, 2019 – 2032
  - Normal Sized Needles
  - Short Needle
  - Intradermal Microinjection
  - Microneedle Arrays
  - Tattoo Devices
  - Without Needle
  - Intradermal Liquid Jet Devices and
  - Ballistic Intradermal Injectors
- Asia Pacific Intradermal Injection Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Tuberculin Skin Test
  - Allergy Test
  - Local Aesthetics
  - Others
- Asia Pacific Intradermal Injection Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Hospitals
  - Diagnostic Laboratories
  - Academics and Research Institutes
  - Others
- Asia Pacific Intradermal Injection Market Estimates (US$ Mn), by Country, 2019 – 2032
  - China
  - Japan
  - South Korea
  - India
  - Australia
  - Rest of Asia Pacific

Middle East & Africa Intradermal Injection Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Intradermal Injection Market Estimates (US$ Mn), by Method, 2019 – 2032
  - Normal Sized Needles
  - Short Needle
  - Intradermal Microinjection
  - Microneedle Arrays
  - Tattoo Devices
  - Without Needle
  - Intradermal Liquid Jet Devices and
  - Ballistic Intradermal Injectors
- Middle East & Africa Intradermal Injection Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Tuberculin Skin Test
  - Allergy Test
  - Local Aesthetics
  - Others
- Middle East & Africa Intradermal Injection Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Hospitals
  - Diagnostic Laboratories
  - Academics and Research Institutes
  - Others
- Middle East & Africa Intradermal Injection Market Estimates (US$ Mn), by Country, 2019 – 2032
  - UAE
  - Saudi Arabia
  - South Africa
  - Rest of MEA

South America Intradermal Injection Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Intradermal Injection Market Estimates (US$ Mn), by Method, 2019 – 2032
  - Normal Sized Needles
  - Short Needle
  - Intradermal Microinjection
  - Microneedle Arrays
  - Tattoo Devices
  - Without Needle
  - Intradermal Liquid Jet Devices and
  - Ballistic Intradermal Injectors
- South America Intradermal Injection Market Estimates (US$ Mn), by Application, 2019 – 2032
  - Tuberculin Skin Test
  - Allergy Test
  - Local Aesthetics
  - Others
- South America Intradermal Injection Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Hospitals
  - Diagnostic Laboratories
  - Academics and Research Institutes
  - Others
- South America Intradermal Injection Market Estimates (US$ Mn), by Country, 2019 – 2032
  - Brazil
  - Argentina
  - Rest of South America

Competition Analysis – Global Intradermal Injection Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
  - The Bristol-Myers Squibb Company
    - Business overview
    - Geographic presence
    - Product portfolio
    - Financial facts
    - Relevant news and strategic view
  - Becton Dickinson
  - Cardinal Health
  - Nanopass
  - Pharmajet
  - Idevax
  - Enusung
  - Crossject
  - Hindustan Syringes and Medical Devices
  - OraSure Technologies Inc.
  - West Pharmaceutical Services Inc.
  - Kyoto Kagaku Co. LTD.
  - Terumo Corporation

Conclusion & Recommendations

Request Sample

Request for Customization

Call with the Author

Frequently asked questions about this report

Which region is anticipated to have the highest market growth for intradermal injections?

North America will be one of the major geographical markets for intradermal injections.

What factors are driving the market for intradermal injections?

In the upcoming years, a number of variables are anticipated to impact the intradermal injection market. The market is expanding as a result of factors like rising intradermal vaccination adoption, rising incidence of various communicable and non-communicable diseases, and rising consumer acceptance of aesthetic procedures.

What are the factors restraining the intradermal injections market growth?

Intradermal injections' risks, side effects, and dosing restrictions, however, are likely to impede market expansion.

What is the Compound Annual Growth Rate (CAGR) of the intradermal injections market from 2023 to 2032?

The global intradermal injections market is estimated to exhibit a CAGR of 10.5% between 2023 to 2032.

What was the market for intradermal injections valued at in 2021?

Intradermal injection market size was estimated to be US$ 3.3 billion in 2021.

Which method dominates the intradermal injections market?

The short needle segment is anticipated to experience the highest CAGR between 2023 and 2032.